Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

A W Roberts1, L Robb, S Rakar

  • 1The Walter and Eliza Hall Institute of Medical Research and Cooperative Research Centre for Cellular Growth Factors, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia.

Insights

Suppressor of cytokine signaling 3 (SOCS3) is crucial for mouse placental development, as its absence leads to embryonic lethality. Hematopoiesis in SOCS3-deficient embryos remains unaffected, indicating SOCS3

Area of Science:

  • Developmental biology
  • Immunology
  • Hematopoiesis

Background:

  • Suppressor of cytokine signaling 3 (SOCS3) is a key regulator in cytokine signaling pathways.
  • SOCS3 plays a role in immune responses and cellular differentiation.
  • Previous studies have not fully elucidated the role of SOCS3 in embryonic development and placental formation.

Purpose of the Study:

  • To investigate the function of SOCS3 during mouse embryonic development.
  • To determine the specific role of SOCS3 in placental development and hematopoiesis.

Main Methods:

  • Generation and analysis of SOCS3-deficient (SOCS3(-/-)) mice.
  • Histological examination of embryonic and placental tissues.
  • Assessment of erythropoiesis and hematopoietic progenitor cell function in vitro.

Main Results:

  • SOCS3(-/-) mice exhibit embryonic lethality between gestational days 11 and 13.
  • Defects in placental development, including reduced spongiotrophoblast and impaired vascularization, were observed in SOCS3(-/-) embryos.
  • Hematopoiesis, including erythroid progenitor cell development and responsiveness to growth factors, was normal in SOCS3(-/-) embryos.

Conclusions:

  • SOCS3 is essential for proper placental development in mice.
  • SOCS3 is dispensable for embryonic hematopoiesis.
  • The embryonic lethality in SOCS3(-/-) mice is attributed to placental insufficiency.